Home -> News

News

OUR NEWS

Arthrosi Therapeutics Released Phase 2 Clinical Data of AR882

2020-11-09

LAGUNA HILLS, CA, November 07, 2020 – Arthrosi Therapeutics, a clinical-stage biopharmaceutical company focused on developing a best-in-class treatment for gout, has completed a Phase 2a clinical trial for company’s lead asset, AR882.

READ MORE

[NeuCyte] NeuCyte Licenses Its Novel Neuronal Programming Technology to Enable Academic Research

2020-07-14

SUNNYVALE, Calif., Dec. 3, 2018 /PRNewswire/ -- NeuCyte, Inc., a leading neuroscience drug discovery company, announced that it has entered a license agreement with Boston Children's Hospital. As part of the agreement, Boston Children's has obtained a non-exclusive license from NeuCyte to manufacture transcription factor Ngn2 programmed induced neurons. The hospital intends to use this technology for internal research, teaching and educational purposes, and to perform services to other academic institutions.

READ MORE

[CITON] UATP Partners With CITCON To Increase Mobile Payment Acceptance

2020-07-04

UATP is proud to be partnering with leading payment technology company CITCON to offer Alipay, WeChat Pay and China UnionPay, the preferred mobile payment options for over one billion Chinese consumers.

READ MORE

[CITON] CITCON and Tulip Team Up to Launch Global Mobile Payment Solution

2020-07-04

Integrated payment technology and omnichannel clienteling enable retailers to provide personalized and seamless shopping experiences

READ MORE

[ScaleFlux] ScaleFlux, Supermicro, and ASA Computers Release Joint Hadoop Solution

2020-06-03

boost hadoop deployments by 30% out-of-the-box

READ MORE